Bionime Corporation (4737) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Bionime Corporation (4737:TWSE), powered by AI.

Current Price
$54.90
Sector
Healthcare
What is the Bionime Corporation stock price forecast?

Bionime Corporation is currently trading at $54.90. View real-time AI analysis on Alpha Lenz.

What is Bionime Corporation insider trading activity?

View the latest insider trading data for Bionime Corporation on Alpha Lenz.

What is Bionime Corporation's P/E ratio?

View Bionime Corporation's valuation metrics on Alpha Lenz.

Bionime Corporation

TWSE · 4737
NT$54.90+0.00(+0.00%)
Ask about Bionime Corporation's future dividend policy...
Alpha Chat Insight

Bionime Corporation's ROE is -9.9%. Explore profitability and growth together.

Ask for details

Company Overview

Bionime Corporation is a company specializing in the design and production of medical diagnostic devices, primarily focusing on blood glucose monitoring systems. Renowned for its innovation in the healthcare sector, Bionime offers a range of products designed to provide accurate, user-friendly results for both personal and professional healthcare settings. The company's core product lines include glucose meters, test strips, and related accessories that cater to the growing global demand for diabetes management solutions. Bionime integrates cutting-edge technology with ergonomic design, ensuring ease of use and reliable data for users. Its products are extensively used across hospitals, clinics, and by individual patients, which underscores their critical role in chronic disease management. Established in 2003 and headquartered in Taichung, Taiwan, Bionime has rapidly expanded its international presence by adhering to stringent regulatory standards, thus gaining widespread trust in various markets. With a focus on continuous improvement and customer care, Bionime Corporation significantly contributes to the medical device landscape, offering essential tools that support impactful health outcomes.

SectorHealthcare
IndustryMedical Instruments & Supplies
0

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$1.84BRevenue
0.00Shares Out
0Employees

Margins

34.15%Gross
-0.44%EBITDA
-11.05%Operating
-13.57%Pre-Tax
-9.75%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

-5.96%Rev 3Yr
1.96%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-3.12%ROA
-9.95%ROE
-3.21%ROIC

Financial Health

NT$423.12MCash & Cash Equivalents
NT$3.53BNet Debt
224.92%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Bionime Corporation (ticker: 4737) is a company listed on TWSE in the Healthcare sector (Medical Instruments & Supplies).

The current price is 54.9 with a P/E ratio of -x and P/B of -x.

ROE is -9.95% and operating margin is -11.05%. Annual revenue is $1.8B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Bionime Corporation (4737) Stock Forecast 2026 $54.90 — Price, Financials & Analyst Targets | Alpha Lenz